The Europe Drug Discovery Informatics Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $418.8 million by 2031. The UK market is exhibiting a CAGR of 9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.7% during (2024 - 2031).
Informatics platforms facilitate the integration and analysis of diverse biological data sources, allowing researchers to gain insights into disease mechanisms, identify biomarkers, and prioritize drug candidates for further development. Furthermore, informatics-driven approaches enhance decision-making and resource allocation throughout the drug discovery pipeline, ultimately accelerating the development of novel therapies and reducing the time and cost of bringing new drugs to market. As the pharmaceutical industry embraces digital transformation, drug discovery informatics is poised to be increasingly critical in driving innovation and addressing unmet medical needs.
The drug discovery informatics market is leading in shaping research and development, leveraging cutting-edge computational and informational technologies to accelerate bringing new therapeutics to market. With the growing complexity of diseases and the need for more efficient drug development processes, drug discovery informatics has emerged as a critical enabler of innovation and efficiency in the pharmaceutical industry. Drug discovery informatics encompasses diverse computational tools, data analysis techniques, and informatics platforms that facilitate various stages of the drug discovery pipeline, from target identification and validation to lead optimization, preclinical studies, and beyond.
Several European countries have launched research and development (R&D) initiatives to foster innovation in healthcare and pharmaceuticals. Horizon Europe is the EU's flagship research and innovation program, with an over €95 billion budget for 2021-2027. It aims to support R&D in various sectors, including healthcare and pharmaceuticals, to address societal challenges and drive economic growth.
The European market for drug discovery informatics is experiencing significant expansion, buoyed by the region's robust healthcare infrastructure and substantial investments in medical devices and technology. Spain, a key player in this arena, boasts a thriving medical devices sector valued at USD 7.4 billion in 2021. The country's substantial healthcare budget of Euro 122.8 billion in 2020, with a notable 70% coming from public sources, underscores its commitment to advancing healthcare services. With an average per capita expenditure of Euro 2,594, Spain provides a fertile ground for adopting innovative healthcare technologies, including drug discovery informatics.
Free Valuable Insights: The Global Drug Discovery Informatics Market will Hit USD 6.5 Billion by 2031, at a CAGR of 10.3%
Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Oracle Corporation
- Accenture PLC
- Thermo Fisher Scientific, Inc.
- Boehringer Ingelheim International GmbH
- Infosys Limited
- Charles River Laboratories International, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Certara, Inc.
- Jubilant Pharmova Limited
Europe Drug Discovery Informatics Market Report Segmentation
By Application
- Drug Discovery
- Drug Development
By Function
- Sequencing & Target Data Analysis
- Molecular Modelling
- Library & Database Preparation
- Docking
- Others
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Drug Discovery Informatics Market, by Application
1.4.2 Europe Drug Discovery Informatics Market, by Function
1.4.3 Europe Drug Discovery Informatics Market, by End User
1.4.4 Europe Drug Discovery Informatics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Drug Discovery Informatics Market by Application
5.1 Europe Drug Discovery Market by Country
5.2 Europe Drug Development Market by Country
Chapter 6. Europe Drug Discovery Informatics Market by Function
6.1 Europe Sequencing & Target Data Analysis Market by Country
6.2 Europe Molecular Modelling Market by Country
6.3 Europe Library & Database Preparation Market by Country
6.4 Europe Docking Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Drug Discovery Informatics Market by End User
7.1 Europe Pharmaceutical Companies Market by Country
7.2 Europe Biotechnology Companies Market by Country
7.3 Europe Contract Research Organizations Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Drug Discovery Informatics Market by Country
8.1 Germany Drug Discovery Informatics Market
8.1.1 Germany Drug Discovery Informatics Market by Application
8.1.2 Germany Drug Discovery Informatics Market by Function
8.1.3 Germany Drug Discovery Informatics Market by End User
8.2 UK Drug Discovery Informatics Market
8.2.1 UK Drug Discovery Informatics Market by Application
8.2.2 UK Drug Discovery Informatics Market by Function
8.2.3 UK Drug Discovery Informatics Market by End User
8.3 France Drug Discovery Informatics Market
8.3.1 France Drug Discovery Informatics Market by Application
8.3.2 France Drug Discovery Informatics Market by Function
8.3.3 France Drug Discovery Informatics Market by End User
8.4 Russia Drug Discovery Informatics Market
8.4.1 Russia Drug Discovery Informatics Market by Application
8.4.2 Russia Drug Discovery Informatics Market by Function
8.4.3 Russia Drug Discovery Informatics Market by End User
8.5 Spain Drug Discovery Informatics Market
8.5.1 Spain Drug Discovery Informatics Market by Application
8.5.2 Spain Drug Discovery Informatics Market by Function
8.5.3 Spain Drug Discovery Informatics Market by End User
8.6 Italy Drug Discovery Informatics Market
8.6.1 Italy Drug Discovery Informatics Market by Application
8.6.2 Italy Drug Discovery Informatics Market by Function
8.6.3 Italy Drug Discovery Informatics Market by End User
8.7 Rest of Europe Drug Discovery Informatics Market
8.7.1 Rest of Europe Drug Discovery Informatics Market by Application
8.7.2 Rest of Europe Drug Discovery Informatics Market by Function
8.7.3 Rest of Europe Drug Discovery Informatics Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
TABLE 1 Europe Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 2 Europe Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Drug Discovery Informatics Market
TABLE 4 Product Launches And Product Expansions– Drug Discovery Informatics Market
TABLE 5 Acquisition and Mergers– Drug Discovery Informatics Market
TABLE 6 Europe Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 7 Europe Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 8 Europe Drug Discovery Market by Country, 2020 - 2023, USD Million
TABLE 9 Europe Drug Discovery Market by Country, 2024 - 2031, USD Million
TABLE 10 Europe Drug Development Market by Country, 2020 - 2023, USD Million
TABLE 11 Europe Drug Development Market by Country, 2024 - 2031, USD Million
TABLE 12 Europe Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 13 Europe Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 14 Europe Sequencing & Target Data Analysis Market by Country, 2020 - 2023, USD Million
TABLE 15 Europe Sequencing & Target Data Analysis Market by Country, 2024 - 2031, USD Million
TABLE 16 Europe Molecular Modelling Market by Country, 2020 - 2023, USD Million
TABLE 17 Europe Molecular Modelling Market by Country, 2024 - 2031, USD Million
TABLE 18 Europe Library & Database Preparation Market by Country, 2020 - 2023, USD Million
TABLE 19 Europe Library & Database Preparation Market by Country, 2024 - 2031, USD Million
TABLE 20 Europe Docking Market by Country, 2020 - 2023, USD Million
TABLE 21 Europe Docking Market by Country, 2024 - 2031, USD Million
TABLE 22 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 23 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 24 Europe Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 25 Europe Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 26 Europe Pharmaceutical Companies Market by Country, 2020 - 2023, USD Million
TABLE 27 Europe Pharmaceutical Companies Market by Country, 2024 - 2031, USD Million
TABLE 28 Europe Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 29 Europe Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 30 Europe Contract Research Organizations Market by Country, 2020 - 2023, USD Million
TABLE 31 Europe Contract Research Organizations Market by Country, 2024 - 2031, USD Million
TABLE 32 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 33 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 34 Europe Drug Discovery Informatics Market by Country, 2020 - 2023, USD Million
TABLE 35 Europe Drug Discovery Informatics Market by Country, 2024 - 2031, USD Million
TABLE 36 Germany Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 37 Germany Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 38 Germany Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 39 Germany Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 40 Germany Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 41 Germany Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 42 Germany Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 43 Germany Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 44 UK Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 45 UK Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 46 UK Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 47 UK Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 48 UK Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 49 UK Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 50 UK Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 51 UK Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 52 France Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 53 France Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 54 France Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 55 France Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 56 France Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 57 France Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 58 France Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 59 France Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 60 Russia Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 61 Russia Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 62 Russia Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 63 Russia Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 64 Russia Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 65 Russia Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 66 Russia Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 67 Russia Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 68 Spain Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 69 Spain Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 70 Spain Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 71 Spain Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 72 Spain Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 73 Spain Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 74 Spain Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 75 Spain Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 76 Italy Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 77 Italy Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 78 Italy Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 79 Italy Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 80 Italy Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 81 Italy Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 82 Italy Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 83 Italy Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 84 Rest of Europe Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 85 Rest of Europe Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 86 Rest of Europe Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 87 Rest of Europe Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 88 Rest of Europe Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 89 Rest of Europe Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 90 Rest of Europe Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 91 Rest of Europe Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 92 Key Information – Oracle Corporation
TABLE 93 Key Information – Accenture PLC
TABLE 94 Key Information – Thermo Fisher Scientific, Inc.
TABLE 95 Key Information – Boehringer Ingelheim International GmbH
TABLE 96 Key Information – Infosys Limited
TABLE 97 key information – Charles River Laboratories International, Inc.
TABLE 98 key Information – Agilent Technologies, Inc.
TABLE 99 key information – Illumina, Inc.
TABLE 100 Key Information – Certara, Inc.
TABLE 101 Key Information – Jubilant Pharmova Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Drug Discovery Informatics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Drug Discovery Informatics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis - Drug Discovery Informatics Market
FIG 8 Europe Drug Discovery Informatics Market share by Application, 2023
FIG 9 Europe Drug Discovery Informatics Market share by Application, 2031
FIG 10 Europe Drug Discovery Informatics Market by Application, 2020 - 2031, USD Million
FIG 11 Europe Drug Discovery Informatics Market share by Function, 2023
FIG 12 Europe Drug Discovery Informatics Market share by Function, 2031
FIG 13 Europe Drug Discovery Informatics Market by Function, 2020 - 2031, USD Million
FIG 14 Europe Drug Discovery Informatics Market share by End User, 2023
FIG 15 Europe Drug Discovery Informatics Market share by End User, 2031
FIG 16 Europe Drug Discovery Informatics Market by End User, 2020 - 2031, USD Million
FIG 17 Europe Drug Discovery Informatics Market share by Country, 2023
FIG 18 Europe Drug Discovery Informatics Market share by Country, 2031
FIG 19 Europe Drug Discovery Informatics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Oracle Corporation
FIG 21 SWOT Analysis: Accenture PLC
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Infosys Limited
FIG 26 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 27 Swot Analysis: Charles River Laboratories International, Inc.
FIG 28 Recent strategies and developments: Agilent Technologies, Inc.
FIG 29 Swot Analysis: Agilent Technologies, Inc.
FIG 30 Recent strategies and developments: Illumina, Inc.
FIG 31 Swot Analysis: Illumina, Inc.
FIG 32 Recent strategies and developments: Certara, Inc.
FIG 33 Swot Analysis: Certara, Inc.
FIG 34 Swot Analysis: Jubilant Pharmova Limited